News | December 17, 2024
Merck to acquire HUB Organoids to advance cell culture portfolio
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies
InnoCell is the brand name for Mitsui Chemicals’ cell culture products and services
Subscribe To Our Newsletter & Stay Updated
